Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Trio Pharmaceuticals Logo
Trio Pharmaceuticals Growth Score
69
CB Rank
50573
Heat Score
62
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.
Founded
obfuscation
PrivateSeed San Diego, California, United States1-10 www.triopharmaceuticals.com/
Biotechnology
Health Care
Medical
Therapeutics
Overview

Trio Pharmaceuticals
Total Funding
obfuscation
Growth Score
69
Heat Score
62

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score69
-9 pts
in past quarter
Heat Score 62
-3 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Trio Pharmaceuticals

CB Rank
50573
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors.
Founded
obfuscation
PrivateSeed San Diego, California, United States1-10 www.triopharmaceuticals.com/
Biotechnology
Health Care
Medical
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation
Seed
OBF
in
obfuscation

Key People

Details

Legal Name Trio Pharmaceuticals, Inc.
Operating Status Active
Company Type For Profit
Founders  Reiner Laus, Shiva Bhowmik
About the Company
Trio Pharmaceuticals is a cancer therapeutics company that develops dual-action drugs for immunogenic tumors. These drugs directly stop tumor growth and selectively stop immunosuppression in the tumor without targeting the current immune checkpoint pathways. The company was founded in 2018 and is headquartered in San Diego, California.
Phone Number +1-765-490-0874
Contact Email shiva@triopharmaceuticals.com
Predictions & Insights

Growth Insight

See this Growth Insight
Trio Pharmaceuticals is
Lorem
 to be growing
Top Contributing Factors
Recently Raised Funding

Growth Prediction

See this Growth Prediction
Top Contributing Factors
Key Employee Changes

Products & Services

TIE-ADC™ (Tumor Immunity Enhancing Antibody-Drug Conjugate™)
A dual-targeting antibody-drug conjugate designed to kill cancer cells and immunosuppressor cells in tumors, reducing tumor burden and immunosuppression.
TRAILBody™
An antibody drug that selectively induces cancer cell death without toxicity by activating endogenous cell death pathways, sparing normal cells.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Trio Pharmaceuticals Logo
Seed Round - Trio Pharmaceuticals
4
obfuscation
Friedman BioVenturesSeed
obfuscation
Seed Round - Trio Pharmaceuticals Logo
Seed Round - Trio Pharmaceuticals
4
obfuscation
Friedman BioVenturesSeed
obfuscation
Seed Round - Trio Pharmaceuticals Logo
Seed Round - Trio Pharmaceuticals
4
obfuscation
Friedman BioVenturesSeed
obfuscation
Seed Round - Trio Pharmaceuticals Logo
Seed Round - Trio Pharmaceuticals
4
obfuscation
Friedman BioVenturesSeed
obfuscation
Seed Round - Trio Pharmaceuticals Logo
Seed Round - Trio Pharmaceuticals
4
obfuscation
Friedman BioVenturesSeed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 3
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Trio Pharmaceuticals Logo
Seed Round - Trio Pharmaceuticals
4
obfuscation
Friedman BioVenturesSeed
obfuscation
Seed Round - Trio Pharmaceuticals Logo
Seed Round - Trio Pharmaceuticals
4
obfuscation
Friedman BioVenturesSeed
obfuscation
Seed Round - Trio Pharmaceuticals Logo
Seed Round - Trio Pharmaceuticals
4
obfuscation
Friedman BioVenturesSeed
obfuscation
Seed Round - Trio Pharmaceuticals Logo
Seed Round - Trio Pharmaceuticals
4
obfuscation
Friedman BioVenturesSeed
obfuscation
Seed Round - Trio Pharmaceuticals Logo
Seed Round - Trio Pharmaceuticals
4
obfuscation
Friedman BioVenturesSeed

Investors

Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 3 Board Members and Advisors 2 Contacts 1

Employee Profiles

Board Members and Advisors

News

News and Press

News•Oct 10, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Oct 8, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Jul 18, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Dec 17, 2024
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

647
895.38%
 in past month

IT Spend

$104.2KThis year, Trio Pharmaceuticals is projected to spend $104.2K on IT, according to Aberdeen.

Interest Signals

TopicSurge Score
Property Graph Logo
Property Graph
69
Valuation Logo
Valuation
69
Design Template Logo
Design Template
67

Active Website Tech Count

3Trio Pharmaceuticals is actively using 3 technologies for its website, according to BuiltWith. These include Viewport Meta, Euro, and  CommonCrawl Top 10m.

Total IP

2The intellectual property of Trio Pharmaceuticals includes 2 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Trio Pharmaceuticals's headquarters? Trio Pharmaceuticals is located in San Diego, California, United States.Who invested in Trio Pharmaceuticals? Trio Pharmaceuticals has 8 investors including Friedman BioVentures and  Life Science Angels.When was the last funding round for Trio Pharmaceuticals? Trio Pharmaceuticals closed its last funding round on
obfuscation
from a Seed round.Who are Trio Pharmaceuticals's competitors? Alternatives and possible competitors to Trio Pharmaceuticals may include Eikon Therapeutics, Seismic Therapeutic, and  Compass Therapeutics.How much funding has Trio Pharmaceuticals raised to date? Trio Pharmaceuticals has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|